IDDI - eClinical and Biostatistical Services for phase I to IV clinical trials
Trial Design . Randomization · Data Management · Biostatistics
Established for more than 23 years, International Drug Development Institute (IDDI), has grown thanks to its niche positioning as a major service provider in the design, collection, analysis and reporting of clinical research data.
IDDI combines expert methodology in Biostatistics with innovative integrated technology (eClinical suite of made-to-measure secure web systems: IWRS and web coding integrated to EDC) to optimize the design and conduct of clinical trials.
Protocol design, centralized randomization and treatment allocation integrated to EDC, data management, biostatistical analysis, clinical study reporting, validation of biomarkers,
support to IDMCs, central statistical monitoring through its affiliate CluePoints, medical writing, expert mission with regulatory agencies .
IDDI has strongly contributed to date to 15 market approvals in Europe and USA and has been involved in over 500 trials to date.
IDDI has a broad expertise in various therapeutic areas and a special focus in oncology, ophthalmology, infectious diseases, cardiology, inflammatory and biosimilars.